Filing Details

Accession Number:
0001209191-14-072446
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-02 17:53:18
Reporting Period:
2014-11-28
Filing Date:
2014-12-02
Accepted Time:
2014-12-02 17:53:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596946 Quotient Ltd QTNT In Vitro & In Vivo Diagnostic Substances (2835) 264719797
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1056630 Zubeen Shroff Elizabeth House, 9 Castle Street
St Helier Y9 JE2 3RT
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2014-11-28 145,473 $9.50 5,239,293 No 4 P Indirect By Galen Partners V LP
Ordinary Shares Acquisiton 2014-11-28 12,422 $9.50 447,400 No 4 P Indirect By Galen Partners International V LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Galen Partners V LP
No 4 P Indirect By Galen Partners International V LP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 150,704 Indirect Galen Management, LLC
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Ordinary Shares Employee Stock Option (right to buy) $8.00 2024-04-29 5,000 5,000 Direct
Ordinary Shares Ordinary Share Warrants $0.00 2014-07-24 2015-10-25 230,331 287,914 Indirect
Ordinary Shares Ordinary Share Warrants $0.00 2014-07-24 2015-10-25 19,669 24,586 Indirect
Ordinary Shares Ordinary Share Option (Right to Buy) $9.95 2024-10-31 5,025 5,025 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2024-04-29 5,000 5,000 Direct
2015-10-25 230,331 287,914 Indirect
2015-10-25 19,669 24,586 Indirect
2024-10-31 5,025 5,025 Direct
Footnotes
  1. In connection with Quotient Limited's initial public offering, 287,914 units were purchased by Galen Partners V LP on 4/30/2014 at a price of $8.00 per unit. Each unit consisted of one Ordinary Share andone warrant to purchase 0.8 of one Ordinary Share. The Ordinary Shares and warrants comprising the units began trading separately on May 24, 2014. Each warrant is exercisable until 5:30 p.m. on October25, 2015 at an exercise price of $8.80 per Ordinary Share.
  2. Consists solely of 5,239,293 ordinary shares held of record by Galen Partners V LP, 447,400 ordinary shares held of record by Galen Partners International V LP and 150,704 ordinary shares held ofrecord by Galen Management, LLC (collectively, "Galen Partners"), as applicable. Zubeen Shroff along with David W. Jahns, and John Wilkerson exercise voting, investment and dispositive rights over thesecurities held of record by Galen Partners. Mr. Shroff disclaims beneficial ownership of these ordinary shares, except to the extent of his proportionate pecuniary interest in such shares.
  3. In connection with Quotient Limited's initial public offering, 24,586 units were purchased by Galen Partners International V LP on 4/30/2014 at a price of $8.00 per unit. Each unit consisted of oneOrdinary Share and one warrant to purchase 0.8 of one Ordinary Share. The Ordinary Shares and warrants comprising the units will began trading separately on May 24, 2014. Each warrant is exercisableuntil 5:30 p.m. on October 25, 2015 at an exercise price of $8.80 per Ordinary Share.
  4. The option becomes exercisable in three equal annual installments beginning April 29, 2015.
  5. The option vests and becomes exercisable in three equal installments beginning October 31, 2014.
  6. The ordinary shares were acquired in connection with the issuer's private placement. Galen Partners V LP acquired 145,473 ordinary shares and Galen Partners International V LP acquired 12,422 ordinary shares.